Co-Diagnostics Analyst Ratings
Co-Diagnostics Analyst Ratings
While ratings are subjective and will change, the latest Co-Diagnostics (CODX) rating was a reiterated with a price target of $0.00 to $6.00. The current price Co-Diagnostics (CODX) is trading at is $3.03, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 02/23/2023 | 98.02% | HC Wainwright & Co. | → $6 | Reiterates | → Buy |
| 11/14/2022 | 98.02% | HC Wainwright & Co. | $9 → $6 | Maintains | Buy |
| 08/15/2022 | 197.03% | HC Wainwright & Co. | $12 → $9 | Maintains | Buy |
| 08/12/2022 | 65.02% | Sidoti & Co. | → $5 | Downgrades | Buy → Neutral |
| 05/16/2022 | 296.04% | HC Wainwright & Co. | $15 → $12 | Maintains | Buy |
| 11/12/2021 | 395.05% | HC Wainwright & Co. | $16 → $15 | Maintains | Buy |
| 03/29/2021 | — | Maxim Group | Downgrades | Buy → Hold | |
| 03/26/2021 | 428.05% | HC Wainwright & Co. | $30 → $16 | Maintains | Buy |
| 12/15/2020 | 890.1% | HC Wainwright & Co. | $29 → $30 | Maintains | Buy |
| 11/17/2020 | 857.1% | HC Wainwright & Co. | $33 → $29 | Maintains | Buy |
| 08/14/2020 | 989.11% | HC Wainwright & Co. | $35 → $33 | Maintains | Buy |
| 05/20/2020 | 890.1% | Maxim Group | → $30 | Upgrades | Hold → Buy |
| 05/18/2020 | 1055.12% | HC Wainwright & Co. | $20 → $35 | Reiterates | → Buy |
| 03/03/2020 | — | Maxim Group | Downgrades | Buy → Hold | |
| 02/24/2020 | 32.01% | HC Wainwright & Co. | $2 → $4 | Maintains | Buy |
| 04/09/2019 | -33.99% | Maxim Group | → $2 | Initiates Coverage On | → Buy |
| 03/11/2019 | -33.99% | HC Wainwright & Co. | → $2 | Initiates Coverage On | → Buy |
| 日期 | 上/下行 | 分析師公司 | 价格目標變更 | 評級變更 | 上一頁/目前評分 |
|---|---|---|---|---|---|
| 02/23/2023 | 98.02% | HC 溫賴特 & 有限公司. | → 6 美元 | 重申 | → 購買 |
| 11/14/2022 | 98.02% | HC 溫賴特 & 有限公司. | 9 美元 → 6 美元 | 維護 | 購買 |
| 2022 年 8 月 15 日 | 197.03% | HC 溫賴特 & 有限公司. | 十二美元 → 9 美元 | 維護 | 購買 |
| 2022 年 12 月 8 日 | 65.02% | 西多迪 & 有限公司. | → 5 美元 | 降級 | 購買 → 中性 |
| 2022 年 5 月 16 日 | 296.04% | HC 溫賴特 & 有限公司. | 15 美元 → 12 美元 | 維護 | 購買 |
| 11/12/2021 | 395.05% | HC 溫賴特 & 有限公司. | 十六元 → 15 美元 | 維護 | 購買 |
| 03/29/2021 | — | 美心集團 | 降級 | 購買 → 持有 | |
| 03/26/2021 | 428.05% | HC 溫賴特 & 有限公司. | 三十元 → 十六美元 | 維護 | 購買 |
| 12/15/2020 | 890.1% | HC 溫賴特 & 有限公司. | 二十九元 → 三十美元 | 維護 | 購買 |
| 11/17/2020 | 857.1% | HC 溫賴特 & 有限公司. | 三十三元 → 二十九美元 | 維護 | 購買 |
| 08/14/2020 | 989.11% | HC 溫賴特 & 有限公司. | 三十五美元 → 三十三美元 | 維護 | 購買 |
| 2020 年 5 月 20 日 | 890.1% | 美心集團 | → 30 美元 | 升級 | 持有 → 購買 |
| 05/18/2020 | 1055.12% | HC 溫賴特 & 有限公司. | 二十美元 → 35 美元 | 重申 | → 購買 |
| 03/03/2020 | — | 美心集團 | 降級 | 購買 → 持有 | |
| 02/24/2020 | 32.01% | HC 溫賴特 & 有限公司. | 兩美元 → 4 美元 | 維護 | 購買 |
| 04/09/2019 | -33.99% | 美心集團 | → 2 美元 | 啟動覆蓋範圍 | → 購買 |
| 03/11/2019 | -33.99% | HC 溫賴特 & 有限公司. | → 2 美元 | 啟動覆蓋範圍 | → 購買 |
What is the target price for Co-Diagnostics (CODX)?
協同診斷 (CODX) 的目標價格是多少？
The latest price target for Co-Diagnostics (NASDAQ: CODX) was reported by HC Wainwright & Co. on February 23, 2023. The analyst firm set a price target for $6.00 expecting CODX to rise to within 12 months (a possible 98.02% upside). 5 analyst firms have reported ratings in the last year.
HC 溫萊特公司於 2023 年 2 月 23 日報導了聯合診斷（納斯達克代碼：CODX）的最新價格目標。該分析師公司設定了 6.00 美元的價格目標，預計 CODX 將在 12 個月內上升（可能上漲 98.02％）。5 家分析師公司在去年報告了評級。
What is the most recent analyst rating for Co-Diagnostics (CODX)?
什麼是共同診斷 (CODX) 的最新分析師評級？
The latest analyst rating for Co-Diagnostics (NASDAQ: CODX) was provided by HC Wainwright & Co., and Co-Diagnostics reiterated their buy rating.
共診斷的最新分析師評級（納斯達克代碼：CODX）由 HC 溫賴特公司提供，並協診重申了他們的購買評級。
When is the next analyst rating going to be posted or updated for Co-Diagnostics (CODX)?
協同診斷 (CODX) 的下一個分析師評級何時會公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Co-Diagnostics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Co-Diagnostics was filed on February 23, 2023 so you should expect the next rating to be made available sometime around February 23, 2024.
分析師在進行廣泛的研究後到達股票評級，其中包括通過公共財務報表，與 Co-Diagnotics 的高管和客戶交談以及收聽盈利會議電話會議。大多數分析師每三個月這樣做一次，因此您應該每年每家公司獲得 4 個評級。協同診斷的最後評級於 2023 年 2 月 23 日提交，因此您應該期望下一個評級將在 2024 年 2 月 23 日左右的某個時間提供。
Is the Analyst Rating Co-Diagnostics (CODX) correct?
分析師等級協同診斷 (CODX) 是否正確？
While ratings are subjective and will change, the latest Co-Diagnostics (CODX) rating was a reiterated with a price target of $0.00 to $6.00. The current price Co-Diagnostics (CODX) is trading at is $3.03, which is within the analyst's predicted range.
儘管評級是主觀的並且會發生變化，但最新的協同診斷（CODX）評級重申，目標價格為 0.00 美元至 6.00 美元。目前的價格協同診斷（CODX）的交易價格為 3.03 美元，這是在分析師的預測範圍內。
